STEDICAL SCIENTIFIC, INC.
See us at Arab Health 2025 · Booth: H1.C50D
Stedical Scientific Inc. is a global tissue engineering and regenerative medicine company. It has a proprietary technology platform for biosynthetic membrane repair. The company has R&D centers and manufacturing facilities in San Diego, California, USA. In 2021, it won the first place among the "Global TOP 10 Wound Management Solution Providers".
Carlsbad, California (CA), United States
Healthcare
Connect with us at
About
Stedical Scientific Inc. is a global tissue engineering and regenerative medicine company. It has a proprietary technology platform for biosynthetic membrane repair. The company has R&D centers and manufacturing facilities in San Diego, California, USA. In 2021, it won the first place among the "Global TOP 10 Wound Management Solution Providers".
Stedical’s Chief Scientific Officer is the inventor and founder of the world’s first biosynthetic membrane repair material. The technology platform can be applied in the fields of wound repair, surgery, orthopedic trauma, neurology, cardiovascular, and other indications. Stedical’s product, PermeaDerm Biosynthetic Wound Matrix, is FDA cleared and reimbursed as Skin Substitute High Cost Group product in the US clinical market.
The company’s core values include building the most innovative and safe products, providing the highest customer service while creating a culture of integrity and appreciation for its employees. Stedical’s products accelerate the clinical application of innovative regenerative medicine technologies around the world, while greatly improving patient outcomes and the clinician experience. The company’s driving spirit and daily efforts are committed to discovering the potential for hidden therapeutic solutions and matching these innovations to unmet clinical needs.
The PermeaDerm product is currently being commercialized in ten countries, and given the growth potential of the globally, Stedical intends to expand to more countries and regions.
Stedical’s Chief Scientific Officer is the inventor and founder of the world’s first biosynthetic membrane repair material. The technology platform can be applied in the fields of wound repair, surgery, orthopedic trauma, neurology, cardiovascular, and other indications. Stedical’s product, PermeaDerm Biosynthetic Wound Matrix, is FDA cleared and reimbursed as Skin Substitute High Cost Group product in the US clinical market.
The company’s core values include building the most innovative and safe products, providing the highest customer service while creating a culture of integrity and appreciation for its employees. Stedical’s products accelerate the clinical application of innovative regenerative medicine technologies around the world, while greatly improving patient outcomes and the clinician experience. The company’s driving spirit and daily efforts are committed to discovering the potential for hidden therapeutic solutions and matching these innovations to unmet clinical needs.
The PermeaDerm product is currently being commercialized in ten countries, and given the growth potential of the globally, Stedical intends to expand to more countries and regions.
